Maternal risk factors for congenital limb deficiencies: A population-based case-control study.
congenital limb deficiency
diabetes
maternal
population-based
pregnancy
risk factor
Journal
Paediatric and perinatal epidemiology
ISSN: 1365-3016
Titre abrégé: Paediatr Perinat Epidemiol
Pays: England
ID NLM: 8709766
Informations de publication
Date de publication:
07 2021
07 2021
Historique:
revised:
04
10
2020
received:
29
03
2020
accepted:
25
10
2020
pubmed:
14
1
2021
medline:
25
11
2021
entrez:
13
1
2021
Statut:
ppublish
Résumé
Risk factors for congenital limb deficiencies are poorly understood. To investigate risk factors for congenital limb deficiencies. We conducted a nationwide population-based case-control (1:5) study in Finland, using national registers on congenital anomalies, births, and induced abortions, cross-linked with data on maternal prescription medicine use obtained from the registers on Reimbursed Drug Purchases and Medical Special Reimbursements. Five hundred and four children with limb deficiencies (241 isolated, 181 syndromic, and 82 other associated anomalies) were identified, and 2,520 controls were matched to cases on residence and year of pregnancy. Non-syndromic cases (n = 323) were subdivided into longitudinal (n = 120), transverse (n = 123), intercalary (n = 24), mixed (n = 18), and unknown (n = 38) deficiencies. Pregestational diabetes was associated with all limb deficiencies (adjusted odds ratio [OR] 12.71, 95% confidence interval [CI] 2.37, 68.25) and with isolated (OR 11.42, 95% CI 2.00, 64.60) deficiencies. Primiparity was associated with increased risk of congenital limb deficiencies among all cases (OR 1.49, 95% CI 1.15, 1.93), isolated cases (OR 1.46, 95% CI 1.09, 1.96), and among cases with longitudinal (OR 1.90, 95% CI 1.24, 2.90) and transverse deficiencies (OR 1.75, 95% CI 1.13, 2.70). Young maternal age (<25 years) was associated with all congenital limb deficiencies (OR 1.40, 95% CI 1.02, 1.90) and transverse deficiencies (OR 1.76, 95% CI 1.05, 2.96). Advanced maternal age (≥35 years) was associated with syndromic (OR 1.82, 95% CI 1.19, 2.78) and transverse deficiencies (OR 1.94, 95% CI 1.06, 3.57). Maternal antiepileptic medication was associated with all (OR 5.77, 95% CI 1.75, 19.04) and with isolated cases (OR 3.83, 95% CI 1.02, 14.34). It is important that pregnant women taking medications, especially antiepileptics, or women with pregestational diabetes are carefully monitored with regard to the occurrence and risk of limb deficiencies in the fetus.
Sections du résumé
BACKGROUND
Risk factors for congenital limb deficiencies are poorly understood.
OBJECTIVE
To investigate risk factors for congenital limb deficiencies.
METHODS
We conducted a nationwide population-based case-control (1:5) study in Finland, using national registers on congenital anomalies, births, and induced abortions, cross-linked with data on maternal prescription medicine use obtained from the registers on Reimbursed Drug Purchases and Medical Special Reimbursements. Five hundred and four children with limb deficiencies (241 isolated, 181 syndromic, and 82 other associated anomalies) were identified, and 2,520 controls were matched to cases on residence and year of pregnancy. Non-syndromic cases (n = 323) were subdivided into longitudinal (n = 120), transverse (n = 123), intercalary (n = 24), mixed (n = 18), and unknown (n = 38) deficiencies.
RESULTS
Pregestational diabetes was associated with all limb deficiencies (adjusted odds ratio [OR] 12.71, 95% confidence interval [CI] 2.37, 68.25) and with isolated (OR 11.42, 95% CI 2.00, 64.60) deficiencies. Primiparity was associated with increased risk of congenital limb deficiencies among all cases (OR 1.49, 95% CI 1.15, 1.93), isolated cases (OR 1.46, 95% CI 1.09, 1.96), and among cases with longitudinal (OR 1.90, 95% CI 1.24, 2.90) and transverse deficiencies (OR 1.75, 95% CI 1.13, 2.70). Young maternal age (<25 years) was associated with all congenital limb deficiencies (OR 1.40, 95% CI 1.02, 1.90) and transverse deficiencies (OR 1.76, 95% CI 1.05, 2.96). Advanced maternal age (≥35 years) was associated with syndromic (OR 1.82, 95% CI 1.19, 2.78) and transverse deficiencies (OR 1.94, 95% CI 1.06, 3.57). Maternal antiepileptic medication was associated with all (OR 5.77, 95% CI 1.75, 19.04) and with isolated cases (OR 3.83, 95% CI 1.02, 14.34).
CONCLUSIONS
It is important that pregnant women taking medications, especially antiepileptics, or women with pregestational diabetes are carefully monitored with regard to the occurrence and risk of limb deficiencies in the fetus.
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
450-458Informations de copyright
© 2021 The Authors. Paediatric and Perinatal Epidemiology published by John Wiley & Sons Ltd.
Références
Bedard T, Lowry RB, Sibbald B, Kiefer GN, Metcalfe A. Congenital limb deficiencies in Alberta-a review of 33 years (1980-2012) from the Alberta Congenital Anomalies Surveillance System (ACASS). Am J Med Genet A. 2015;167A(11):2599-2609.
Wilcox WR, Coulter CP, Schmitz ML. Congenital limb deficiency disorders. Clin Perinatol. 2015;42(2):281-300.
Vargesson N. The teratogenic effects of thalidomide on limbs. J Hand Surg Eur. 2019;44(1):88-95.
Janerich DT, Piper JM, Glebatis DM. Oral contraceptives and congenital limb-reduction defects. N Engl J Med. 1974;291(14):697-700.
Czeizel A, Keller S, Bod M. An aetiological evaluation of increased occurrence of congenital limb reduction abnormalities in Hungary, 1975-1978. Int J Epidemiol. 1983;12(4):445-449.
Brent RL. Nongenital malformations following exposure to progestational drugs: The last chapter of an erroneous allegation. Birth Defects Res A Clin Mol Teratol. 2005;73(11):906-918. Review.
Aro T, Heinonen OP, Saxén L. Risk indicators of reduction limb defects. J Epidemiol Community Health. 1983;37(1):50-56.
Polednak AP, Janerich DT. Maternal factors in congenital limb-reduction defects. Teratology. 1985;32(1):41-50.
Caspers KM, Romitti PA, Lin S, Olney RS, Holmes LB, Werler MM. National Birth Defects Prevention Study. Maternal periconceptional exposure to cigarette smoking and congenital limb deficiencies. Paediatr Perinat Epidemiol. 2013;27(6):509-520.
Martínez-Frías ML, Bermejo E, Rodríguez-Pinilla E, Frías JL. Risk for congenital anomalies associated with different sporadic and daily doses of alcohol consumption during pregnancy: a case-control study. Birth Defects Res A Clin Mol Teratol. 2004;70(4):194-200.
Firth HV, Boyd PA, Chamberlain PF, MacKenzie IZ, Morriss-Kay GM, Huson SM. Analysis of limb reduction defects in babies exposed to chorionic villus sampling. Lancet. 1994;343(8905):1069-1071.
Oddy WH, De Klerk NH, Miller M, Payne J, Bower C. Association of maternal pre-pregnancy weight with birth defects: evidence from a case-control study in Western Australia. Aust N Z J Obstet Gynaecol. 2009;49(1):11-15.
Källén B, Finnström O, Lindam A, Nilsson E, Nygren KG, Otterblad PO. Congenital malformations in infants born after in vitro fertilization in Sweden. Birth Defects Res A Clin Mol Teratol. 2010;88(3):137-143.
Davies MJ, Moore VM, Willson KJ, et al. Reproductive technologies and the risk of birth defects. N Engl J Med. 2012;366(19):1803-1813.
Shaw GM, O'Malley CD, Wasserman CR, Tolarova MM, Lammer EJ. Maternal periconceptional use of multivitamins and reduced risk for conotruncal heart defects and limb deficiencies among offspring. Am J Med Genet. 1995;59(4):536-545.
Botto LD, Olney RS, Erickson JD. Vitamin supplements and the risk for congenital anomalies other than neural tube defects. Am J Med Genet. 2004;125C(1):12-21. Review.
Aro T. Maternal diseases, alcohol consumption and smoking during pregnancy associated with reduction limb defects. Early Hum Dev. 1983;9(1):49-57.
Källén B. A prospective study of some aetiological factors in limb reduction defects in Sweden. J Epidemiol Community Health. 1989;43(1):86-91.
Klungsøyr K, Nordtveit TI, Kaastad TS, Solberg S, Sletten IN, Vik AK. Epidemiology of limb reduction defects as registered in the Medical Birth Registry of Norway, 1970-2016: Population based study. PLoS One. 2019;14(7):e0219930.
Froster UG, Baird PA. Congenital defects of lower limbs and associated malformations: a population-based study. Am J Med Genet. 1993;45(1):60-64.
Aberg A, Westbom L, Källén B. Congenital malformations among infants whose mothers had gestational diabetes or preexisting diabetes. Early Hum Dev. 2001;61(2):85-95.
Becerra JE, Khoury MJ, Cordero JF, Erickson JD. Diabetes mellitus during pregnancy and the risks for specific birth defects: a population-based case-control study. Pediatrics. 1990;85(1):1-9.
Correa A, Gilboa SM, Besser LM, et al. Diabetes mellitus and birth defects. Am J Obstet Gynecol. 2008;199(3):237.e1-e9.
Dukhovny S, Van Bennekom CM, Gagnon DR, et al. Metformin in the first trimester and risks for specific birth defects in the National Birth Defects Prevention Study. Birth Defects Res. 2018;110(7):579-586.
Tinker SC, Gilboa SM, Moore CA, et al. Specific birth defects in pregnancies of women with diabetes: National Birth Defects Prevention Study, 1997-2011. Am J Obstet Gynecol. 2020;222(2):176.e1-176.e11.
Nielsen GL, Nørgard B, Puho E, Rothman KJ, Sørensen HT, Czeizel AE. Risk of specific congenital abnormalities in offspring of women with diabetes. Diabet Med. 2005;22(6):693-696.
Pakkasjärvi N, Ritvanen A, Herva R, Peltonen L, Kestilä M, Ignatius J. Lethal congenital contracture syndrome (LCCS) and other lethal arthrogryposes in Finland-an epidemiological study. Am J Med Genet A. 2006;140A(17):1834-1839.
Leoncini E, Botto LD, Cocchi G, et al. How valid are the rates of Down syndrome internationally? Findings from the International Clearinghouse for Birth Defects Surveillance and Research. Am J Med Genet A. 2010;152A(7):1670-1680.
Gissler M, Teperi J, Hemminki E, Meriläinen J. Data quality after restructuring a national medical registry. Scand J Soc Med. 1995;23(1):75-80.
The Social Insurance Institution of Finland. 2020. https://www.kela.fi/tilastojulkaisut_suomen-laaketilasto. Accessed March 25, 2020.
Stothard KJ, Tennant PW, Bell R, Rankin J. Maternal overweight and obesity and the risk of congenital anomalies: a systematic review and meta-analysis. JAMA. 2009;301(6):636-650.
Koskimies E, Lindfors N, Gissler M, Peltonen J, Nietosvaara Y. Congenital upper limb deficiencies and associated malformations in Finland: a population-based study. J Hand Surg Am. 2011;36(6):1058-1065.
Syvänen J, Nietosvaara Y, Ritvanen A, Koskimies E, Kauko T, Helenius I. High risk for major nonlimb anomalies associated with lower-limb deficiency: a population-based study. J Bone Joint Surg Am. 2014;96(22):1898-1904.
International Clearinghouse for Birth Defects Surveillance and Research. 2020. http://www.icbdsr.org/. Accessed March 25, 2020.
Heinke D, Rich-Edwards JW, Williams PL, et al. National Birth Defects Prevention Study. Quantification of selection bias in studies of risk factors for birth defects among livebirths. Paediatr Perinat Epidemiol. 2020;34(6):655-664.
Inkster M, Fahey T, Donnan P, Leese G, Mires G, Murphy D. Poor Glycated Haemoglobin Control and Adverse Pregnancy Outcomes in Type 1 and Type 2 Diabetes Mellitus: Systematic Review of Observational Studies. BMC Pregnancy Childbirth. 2006;30(6):30.
Meinilä J, Koivusalo SB, Valkama A, et al. Nutrient intake of pregnant women at high risk of gestational diabetes. Food Nutr Res. 2015;19(59):26676.
Duong HT, Hoyt AT, Carmichael SL, et al. National Birth Defects Prevention Study. Is maternal Parity an independent risk factor for birth defects? Birth Defects Res A Clin Mol Teratol. 2012;94(4):230-236.
Rodríguez-Pinilla E, Arroyo I, Fondevilla J, García MJ, Martínez-Frías ML. Prenatal exposure to valproic acid during pregnancy and limb deficiencies: a case-control study. Am J Med Genet. 2000;90(5):376-381.
Langer B, Haddad J, Gasser B, Maubert M, Schlaeder G. Isolated fetal bilateral radial ray reduction associated with valproic acid usage. Fetal Diagn Ther. 1994;9(3):155-158.
Heinonen OP, Slone D, Monson RR, Hook EB, Shapiro S. Cardiovascular birth defects and antenatal exposure to female sex hormones. N Engl J Med. 1977;296(2):67-70.
Lammer EJ, Cordero JF. Exogenous sex hormone exposure and the risk for major malformations. JAMA. 1986;255(22):3128-3132.
Charlton BM, Mølgaard-Nielsen D, Svanström H, Wohlfahrt J, Pasternak B, Melbye M. Maternal use of oral contraceptives and risk of birth defects in Denmark: prospective, nationwide cohort study. BMJ. 2016;6(352):h6712.
Berntsen S, Söderström-Anttila V, Wennerholm UB, et al. The health of children conceived by ART: 'the chicken or the egg?'. Hum Reprod Update. 2019;25(2):137-158.
Crider KS, Cleves MA, Reefhuis J, Berry RJ, Hobbs CA, Hu DJ. Antibacterial medication use during pregnancy and risk of birth defects: National Birth Defects Prevention Study. Arch Pediatr Adolesc Med. 2009;163(11):978-985.
Malm H, Martikainen J, Klaukka T, Neuvonen PJ. Prescription drugs during pregnancy and lactation-a Finnish register-based study. Finnish Register-Based Study. Eur J Clin Pharmacol. 2003;59(2):127-133.